acetylcysteine has been researched along with Diabetic Angiopathies in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, Q; Hu, K; Liu, X; Liu, Z; Quan, J | 1 |
| Bergo, RR; Berwanger, O; Buehler, A; Cantarelli, MJ; Carvalho, VO; Castello-Júnior, HJ; Cavalcanti, AB; da Motta, PA; Kodama, A; Mangione, JA; Nunes, PM; São Thiago, LE; Sousa, AM; Sousa, JE; Victor, E | 1 |
| Grutzmacher, C; Morrison, ME; Park, S; Sheibani, N; Sorenson, CM; Zhao, Y | 1 |
| Cosso, L; Cottalasso, D; Maineri, EP; Marinari, UM; Menini, S; Odetti, P; Patriarca, S; Pesce, C; Pronzato, MA; Traverso, N; Valentini, S | 1 |
| Irie, K; Maru, Y; Muraki, T; Ohba, K; Uchida, Y; Yoshioka, T | 1 |
| Berchio, A; Bergamini, S; Brocato, L; Della Casa, L; Gigliardi, VR; Iannone, A; Manzato, E; Martina, V; Masha, A; Massarenti, P; Settanni, F | 1 |
| Asahi, M; Che, W; Higashiyama, S; Kaneto, H; Okado, A; Takahashi, M; Taniguchi, N | 1 |
| Pieper, GM; Siebeneich, W | 1 |
| Hattori, S; Hattori, Y; Kasai, K; Sato, N | 1 |
| Matsuzaki, T; Sakanashi, M | 1 |
2 trial(s) available for acetylcysteine and Diabetic Angiopathies
| Article | Year |
|---|---|
Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Diabetic Angiopathies; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Placebos; Risk Factors; Treatment Failure | 2013 |
Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes.
Topics: Acetylcysteine; Administration, Oral; Aged; Arginine; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Placebos; Systole | 2008 |
8 other study(ies) available for acetylcysteine and Diabetic Angiopathies
| Article | Year |
|---|---|
HADC regulates the diabetic vascular endothelial dysfunction by targetting MnSOD.
Topics: Acetylcysteine; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Diabetic Angiopathies; Endothelial Cells; Gene Expression Regulation; Gene Knockdown Techniques; Glucose; Histone Deacetylase 2; Humans; Metalloporphyrins; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase | 2018 |
Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes.
Topics: Acetylcysteine; Animals; Cell Adhesion; Cell Movement; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Endothelial Cells; Extracellular Matrix Proteins; Fibronectins; Kidney; Kidney Failure, Chronic; Male; Mice; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Osteopontin; Vascular Endothelial Growth Factor A | 2013 |
Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes.
Topics: Acetylcysteine; Animals; Anticoagulants; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hydroxyethylrutoside; Kidney; Male; Rats; Rats, Wistar; Skin; Taurine; Time Factors | 2003 |
Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Adipocytes; Aldehydes; Animals; Antioxidants; Buthionine Sulfoximine; Cells, Cultured; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Free Radical Scavengers; Glycation End Products, Advanced; Lipid Peroxidation; Male; NF-kappa B; Oxidative Stress; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred OLETF; Reactive Oxygen Species; RNA, Messenger; Up-Regulation | 2004 |
Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in
Topics: Acetylcysteine; Animals; Aorta, Thoracic; Arteriosclerosis; Cell Nucleus; Cells, Cultured; Cycloheximide; Dactinomycin; Deoxyglucose; Diabetic Angiopathies; Epidermal Growth Factor; Gene Expression; Guanidines; Heparin; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Kinetics; Muscle, Smooth, Vascular; Peroxides; Pyruvaldehyde; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Transcription, Genetic | 1997 |
Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction.
Topics: Acetylcysteine; Animals; Aorta, Thoracic; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Free Radical Scavengers; Male; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley | 1998 |
High-glucose-induced nuclear factor kappaB activation in vascular smooth muscle cells.
Topics: Acetylcysteine; Analysis of Variance; Animals; Antioxidants; Cells, Cultured; Diabetic Angiopathies; Enzyme Inhibitors; Glucose; Glutathione; Indoles; Male; Maleimides; Mannitol; Muscle, Smooth, Vascular; NF-kappa B; Protein Kinase C; Rats; Rats, Wistar; Stimulation, Chemical; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
Comparison of the development of tolerance to nitroglycerin in aortic preparations isolated from non-diabetic and diabetic rats.
Topics: Acetylcysteine; Animals; Aorta, Thoracic; Blood Glucose; Culture Techniques; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Drug Tolerance; Glycated Hemoglobin; Male; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nitroglycerin; Norepinephrine; Rats; Rats, Inbred Strains; Vasodilation; Vasodilator Agents | 1992 |